Clinical Trials Directory

Trials / Unknown

UnknownNCT04687124

EPA Supplementation in Cancer Patients Receiving Abdominal Radiotherapy -

N-3 Fatty Acid EPA Supplementation in Cancer Patients Receiving Abdominal Radiotherapy - A Randomised Controlled Trial.

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
26 (estimated)
Sponsor
Jens Rikardt Andersen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Malnutrition occurs frequently in patients with cancer during and after radiotherapy to the gastrointestinal (GI) area and can lead to negative outcomes. N-3 fatty acids from fish, especially eicosapentaenoic acid (EPA) may possess anticachectic properties. The aim of this study is to investigate the effect of two nutritional interventions; dietary counselling and an oral nutritional supplement (ONS) containing 2.2 g of the n-3 fatty acid EPA (Forticare®) or standard care, including dietary counselling and protein supplementation when needed.

Detailed description

Methods: Outpatients commencing radiotherapy to the GI area due to dissiminated cancer are randomized to receive dietary counselling and daily fish-oil supplementation over a 5-7 week period, or standard care. Outcome parameters are measured at baseline (onset of radiotherapy), week 5, and 12 weeks after commencing radiotherapy, with one additional measurement of body weight at week 2. Quality of life (QoL) is measured using the EORTC QLQ-C30 questionnaire. Radiotherapy-related side effects are assessed using a questionnaire developed specifically for this study. Data from a historical control group collected in a previous observational study is included in this study to compare incidence of weight loss.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFish oilDietary counseling including an oral nutritional supplement (ONS) containing 2.2 g of n-3 fatty acid EPA (Forticare®)
OTHERstandard careNo specified intervention

Timeline

Start date
2018-02-15
Primary completion
2021-01-01
Completion
2021-02-01
First posted
2020-12-29
Last updated
2020-12-29

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04687124. Inclusion in this directory is not an endorsement.